Curriculum Vitae. CV Chairman ITERA Life-Sciences Forum: Personal data:



Similar documents
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

FACULTY OF ALLIED HEALTH SCIENCES

FACULTY OF MEDICAL SCIENCE

CURRICULUM VITAE Conches (Swtzerland) (personal assistant) Private phone number

Personalized medicine in China s healthcare system

THE LINCOLN INSTITUTE OF HEALTH

Join our scientific talent community

Increasing Innovation in R&D - Seizing early stage external growth opportunities

To be taught at the Ausia Biotech Aseptic Training Center in Hangzhou China

E UROPEAN PERSONAL INFORMATION

AREAS OF CONCENTRATION

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

Ph.D. in Molecular Medicine

Roche Position on Human Stem Cells

7- Doctoral Degree in Public Health and Public Health Sciences (Majoring Microbiology)

Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota

TRACKS GENETIC EPIDEMIOLOGY

SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS

GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE

Stemlife tomorrow s lifeline

TERUMO Corporation Business Strategy Conference

BACHELOR OF SCIENCE IN MICROBIOLOGY

Molecular Biotechnology Master s Degree Program

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.

CAREERS IN BIOMEDICAL SCIENCE & THE IBMS. Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology

LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi

MOLOGEN AG German Equity Forum 2015

Future Oncology: Technology, Products, Market and Service Opportunities

Nuevas tecnologías basadas en biomarcadores para oncología

Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015

New York Bio Conference Mark J. Alles Chief Executive Officer

TRACKS INFECTIOUS DISEASE EPIDEMIOLOGY

Editorial. Yves Levy, Executive Director

Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission

ITT Advanced Medical Technologies - A Programmer's Overview

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare

Course Descriptions. I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students)

Amel Abd Allah Hashim Ahmed

MOLOGEN AG. Q1 Results 2015 Conference Call Dr. Matthias Schroff Chief Executive Officer. Berlin, 12 May 2015

Biomedical Engineering Medical Faculty Mannheim, Heidelberg University

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives

Doctoral Program Department of Microbiology and Immunology

Bachelor of Science in Applied Bioengineering

1. Program Title Master of Science Program in Biochemistry (International Program)

The National Centre for Biomedical Engineering Science

Sepax. your child s cord blood is in safe hands. World leader in adult stem cell processing

Master s of Science (M.S.) in Infectious Disease and Immunology

Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes

7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology)

Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO

Educational Opportunities at Temple University. Deborah B. Nelson, Ph.D. January 21, 2012

Organ on Chip. Developing tools for new, better and personalized therapies. Organ on Chip

Technology funding opportunities at the National Cancer Institute

CURRICULUM VITAE. Igor V. Maslov Sasazuka, Shibuya-ku Phone: +81 (80) Web:

The Commercialization of Technology Concepts into Medical Products

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry

The Academy of Clinical Science and Laboratory Medicine Pathways to Fellowship

Appendices Master s degree programme Biomedical Engineering

15350 Sherman Way, Suite 350 Van Nuys, CA Phone Fax April 17, 2015.

Biostatistics Credit Integrated and Interdisciplinary Training 2/7 Credit

Clinical Research Infrastructure

Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health

Groundbreaking Collaborative Clinical Trial Launched

This is GE Healthcare

BIOLOGICAL SCIENCES REQUIREMENTS [63 75 UNITS]

Sponsoring concept. International MD/PhD Program Molecular Medicine. Hannover Medical School, Germany. Content. I. Mission and Aims 2

Janssen Research & Development 3210 Merryfield Row San Diego, CA 92121

Bio Deutschland CEO & CFO-Meeting 29. November Unternehmertum in den Life Sciences am Beispiel der Geschichte von Miltenyi Biotec

PROJECT GROUP FOR AUTOMATION IN MEDICINE AND BIOTECHNOLOGY IN MANNHEIM BIOPROCESS ENGINEERING

Biochemistry Major Talk Welcome!!!!!!!!!!!!!!

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

The Evolution of Graduate Education in the College of Medicine. Office of Graduate & Postdoctoral Affairs School of Basic Biomedical Sciences

Hong Kong Poised to be the Asia s Biotechnology Hub

School of Public Health and Health Services Department of Epidemiology and Biostatistics

FOR TEXTILES. o Kuchipudi-I] textiles. Outdoor Activity Based Courses. Camp

Top 10 global cord blood banks

Innovation Platform: Sudden Cardiac Death

Curriculum Vitae SILVIA PREITE

How To Learn More About Melanoma

Professional Science Masters Degrees. What are PSM degrees?

Master of Science in Molecular Biology

Fit for Health International Strategy Development Training Innovative Business Solutions and Smart Financing

CV - Curriculum Vitae

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Human stem cell research: a novel technology that will benefit patients Information and Position Paper

Transcription:

CV Chairman ITERA Life-Sciences Forum: Curriculum Vitae Personal data: Name: Ramon First name: Albert Nationality: Belgian Place/ date of birth: Torhout, Belgium 30.03.1940 Address: Stationsstraat 56/9, B-3620 Lanaken Education: - Doctor in medical and biomedical Sciences. - Euro Doctor certificate in Immunology (Auto Immune Diseases and Immunology) - Master in Business Administration (MBA), Strategic Marketing - Boerhaeve Certificate Infections Diseases Job experience ( Functions) Institution 1: Function: Institution 2: Function: University Hospital of Antwerp, Belgium Department of Gastroenterohepatology (Immunology and Infections diseases) Consultant Institute of Genetics, Molecular biology, Cologne, Germany Investigator Research Projects

References: 2010 Awarded with the Otto Meyerhof Price 2010-2013 in Neuss, Germany Otto Meyerhof (Nobel Price 1922) 2011 As President of ITERA, received the UNESCO recognition of the International Code of Ethics, presented by the UNESCO Chair of BioEthics and Human Rights Prof Dr Alberto Garcia Gomez (21 November 2011) 2011 Invited by the The University of Queensland Australia to participate on the Comparative Study of Processses, Systems and Regulations in Manufacturing and Application of Stem Cells and other Cell Therapies Invited speaker at the 4th Annual Congress of Industrial Biotechnology 2011 China Dalian 2010 Invited Guest lector at the Theodor Bilhartz Institute Cairo-Egypt 2010 Member of different Scientific Societies BASL, IPLASS, GSZ, ISHD 2010 Elected as member of the Advisory Board of Directors Unithink (DOMO-group) 2010 Invited as ITERA Chairman at the World Congress TERMIS in Vienna 2012 (Tissue Engineering and Regenerative Medicine Society) 1989-2010 Consultant of Immunologic and Infectious Diseases, at the University Hospital of Antwerp, dept. Gastroenterohepatology headed by Prof. Dr. P. Pelckmans, and Prof. Dr. P. Michielsen 2009 Nanotechnology in Medicine, R&D Project in cooperation with WFUBMC, ITERM, Vision4 Life-Sciences, and ECMTA. 2009 Guest lector at the Baptist Wake Forest University, Institute for Tissue Engineering and Regenerative Medicine 2009 Founding member of ITERM ( Institute of Tissue Engineering and Regenerative Medicine) at Lukas Hospital Neuss, Germany 2009 CMO Unithink (Chief Medical Officer) 2008 Organizer of the 4 th Symposium ITERA The theme of this year s workshop is Stem Cells: From the basic research to the pre-clinical and clinical applications. 2008 Invited speaker on the C.E. Alken-Preisträger Mannheim. 2007 Study Project: Optimization and application of a nanotechnology based amplification technique for visualizing various biomolecules. Prof. Marc Ramael, Prof. Dr. A. Ramon

2007 Organizer of the 3 rd Symposium ITERA, Theme 3 rd symposium: Stem Cells from the cord-blood, cord and placenta; scientific approaches, pre-clinical and clinical applications. 2007 Founder and CEO Vision4 Life-Sciences, Think tank for Innovative Applications in Pharma- and Biotech Industries. 2007-2009 Co-investigator for 8 Projects submitted for the EU Frame Works, 3 projects awarded. ITERA members participated in HEPADIB HYPERLAB 2006 Organizer of the 2 nd ITERAsymposium, Research Project Hepatic Cells, Isolation, differentiation, characterization and functional properties. Project leader A. Ramon 2005 Organizer of the 1 st ITERA symposium Result ITERA workshops, EU project CRYSTAL, Cryo-banking of Stem Cells for Human Therapeutic AppLication or CRYSTAL. Leading Prof. Dr. Hesschler, (Univ. Cologne in 5 EU Universities and one SME Cryo-Save. European s largest Private Family Stem Cell Bank) 2004 Co-Founder of ECMTA (European Centre of Medical and Technical Applications), Director Dr. A. Jung and Mss. Dr. Jung Paul Schalluckstrasse 8, 50939 Köln 2004 Founder und Initiator European Centre of Imaging and Biometry ECIMB Leuven, Belgium Training Centre for diagnostic Radiology 2004 Founder, Initiator and Chairman ITERA (International Tissue Engineering Research Association) 2004 Invited guest lector Stem Cell Institute Minneapolis, Minnesota, U.S.A (December 2004) 2004 Co-Investigator in COOP 2004-512855: Project New Vaccination Therapies for Lung Cancer Research & Development of the RIDIS system 2003 (Real Intelligent Data Informatics System) Product Cooperation with ZeitControl Minden and Unithink, A Platform for individual clinical data. 2003 AIMO Coordinator and partner in Design and Optimization of an RNA-modified Dendritic Cell Vaccine for Cancer. Univ. Hospital Antwerp, UZA

2002 Co-author. Molecular diagnosis and Lab-on-a-Strip. 2000 Founder und Chairman AIMO Organiser of different Workshops in Maastricht (AIMO = Autologous ImmunoModulated Onco-Vaccination therapy group) 2000 Scientific advisor EUREGIO Biotechnology Park, University Maastricht, Drs. René Vleugels 1999 Investigator and Research Collaboration Fibrosis Marker with Bayer AG Leverkussen Germany 1999 Co-Author Handbook Immunopathology of Liver Diseases: An Overview Diagnostic and Clinical Aspects. Authors: Prof. Dr. Krueger GRF, A. Ramon AMC 1999 Guest editor InterVirology, International Journal Novel Immunology Aspects of CMV-Related Diseases. Pathogenesis, Diagnosis, and Therapy 1998 Elected member of the International Scientific Professionals (Who s WHO) 1998 Co-organizer and speaker at the International Workshop on HSV infections, Kerkrade, Netherlands headed by Prof. Dr. Krueger GRF 1996-1998 Co-author Study Protocol on Cytokines in Obesity, Are circulating cytokines playing a role in obesity. A CYTOB-pilot study. headed by Prof. Dr. Van Gaal, University Hospital, Antwerp Dept. Endocrinology 1994 1997 Co investigator in a Benelux Hepatitis C study Protocol. 1992-1997 Consultant Dept of Microbiology at the University of Maastricht. Investigator CMV patent. 1996 CMV Patent, Co-author: Human Cytomegalovirus Antigen and its use (Triple Antigen) n 5.800.952 1995 Chairman and speaker ELAS meeting Brussels Cytokines and Liver diseases, New Biomarkers. Hypothesis as novel Biomarkers in Liver dieases. (European Ligand Assay Society) 1994 Genzyme, Virotech Award, Award for the Contribution in R&D and QCM of different projects

1992 Organon Teknika Award (AKZO Nobel Award 1992): Partner in Research and Development 1990 Co-author of Clinical Study of Psychoneuro-Immunological and Endocrine Network Regulation of Growth and Metastasis in Human Breast Cancer Patients. Project Officer: Prof. Dr. GRF Krueger 1989 Invited guest-lector at the University of Houston Medical School. 1989 Invited guest lector : Lyme Project at the Gustav Liebig University, Prof. Dr. Wellensiek 1989 Co-founder International Institute of Immunopathology, Köln, (USA, Japan, Mexico) Director Prof. Dr. GRF Krueger 1986 1989 Co-investigator in an EU Frame Work Project n 86400465DE07PUJU1 Pathogenesis of Malignant Lymphomas Epidemiology Immunopathology and Virology studies in prelymphomatous conditions (incl. AIDS) and in malignant lymphomas. Director Prof. Dr. GRF Krueger 1984 1986 Co-investigator in a Clinical Trial, International IVIG Study protocol in ARC (Aids Related Complex) Prof. Dr. Krueger GRF, (visiting Fellow Prof. Dr. Gallo)